Search LD-1 & LD-2 Reports Registrations & Quarterly Activity
Loading...
Registrant Name | Client Name | Report Type | Amount Reported |
Filing Year | Posted |
---|---|---|---|---|---|
ABBVIE, INC. | ABBVIE INC. | 3rd Quarter - Amendment | $1,230,000.00 | 2017 | 03/28/2019 @ 09:48 AM |
ABBVIE, INC. | ABBVIE INC. | 1st Quarter - Report | $2,890,000.00 | 2018 | 04/20/2018 @ 04:45 PM |
ABBVIE, INC. | ABBVIE INC. | 3rd Quarter - Report | $1,200,000.00 | 2017 | 10/20/2017 @ 03:47 PM |
ABBVIE, INC. | ABBVIE INC. | 1st Quarter - Report | $2,460,000.00 | 2017 | 04/20/2017 @ 03:08 PM |
ABBVIE, INC. | ABBVIE INC. | 4th Quarter - Report | $1,280,000.00 | 2017 | 01/22/2018 @ 03:00 PM |
ABBVIE, INC. | ABBVIE INC. | 2nd Quarter - Report | $790,000.00 | 2018 | 07/20/2018 @ 12:10 PM |
ABBVIE, INC. | ABBVIE INC. | 2nd Quarter - Report | $720,000.00 | 2017 | 07/20/2017 @ 03:51 PM |
AMERICAN COUNCIL ON EDUCATION | AMERICAN COUNCIL ON EDUCATION | Mid-Year Report | $80,000.00 | 2006 | 08/11/2006 @ 12:00 AM |
AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES | AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES | 2nd Quarter - Amendment | $660,000.00 | 2016 | 07/27/2016 @ 12:30 PM |
AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES | AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES | 2nd Quarter - Report | $650,000.00 | 2016 | 07/19/2016 @ 11:23 AM |
AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES | AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES | 2nd Quarter - Report | $650,000.00 | 2016 | 07/19/2016 @ 11:23 AM |
AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES | AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES | 2nd Quarter - Report | $650,000.00 | 2016 | 07/19/2016 @ 11:23 AM |
AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES | AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES | 2nd Quarter - Amendment | $660,000.00 | 2016 | 07/27/2016 @ 12:30 PM |
AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES | AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES | 2nd Quarter - Amendment | $660,000.00 | 2016 | 07/27/2016 @ 12:30 PM |
ARIZONA STATE UNIVERSITY | ARIZONA STATE UNIVERSITY | Mid-Year Report | $49,000.00 | 2007 | 07/25/2007 @ 07:08 PM |
ARIZONA STATE UNIVERSITY | ARIZONA STATE UNIVERSITY | Year-End Report | $51,000.00 | 2007 | 02/07/2008 @ 02:11 PM |
ARIZONA STATE UNIVERSITY | ARIZONA STATE UNIVERSITY | 1st Quarter - Report | $28,500.00 | 2008 | 04/16/2008 @ 06:25 PM |
ASSOCIATION FOR ACCESSIBLE MEDICINES | ASSOCIATION FOR ACCESSIBLE MEDICINES | 1st Quarter - Report | $510,000.00 | 2024 | 04/22/2024 @ 11:38 AM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 1st Quarter - Report | $1,081,000.00 | 2019 | 04/22/2019 @ 03:50 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 2nd Quarter - Report | $1,045,000.00 | 2019 | 07/22/2019 @ 03:30 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 3rd Quarter - Report | $1,127,000.00 | 2019 | 10/17/2019 @ 03:39 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4th Quarter - Report | $1,137,000.00 | 2019 | 01/21/2020 @ 05:44 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 1st Quarter - Report | $982,000.00 | 2020 | 04/20/2020 @ 07:34 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 2nd Quarter - Report | $1,316,000.00 | 2020 | 07/20/2020 @ 06:04 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 3rd Quarter - Report | $1,068,000.00 | 2021 | 10/20/2021 @ 02:15 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4th Quarter - Report | $1,035,000.00 | 2020 | 01/21/2021 @ 05:20 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 2nd Quarter - Report | $1,339,000.00 | 2018 | 07/20/2018 @ 03:40 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 2nd Quarter - Report | $1,187,000.00 | 2021 | 07/20/2021 @ 07:12 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 1st Quarter - Report | $1,174,000.00 | 2018 | 04/20/2018 @ 12:34 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4th Quarter - Report | $892,000.00 | 2018 | 01/22/2019 @ 01:54 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 3rd Quarter - Report | $857,000.00 | 2018 | 10/22/2018 @ 04:26 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4th Quarter - Report | $1,042,000.00 | 2017 | 01/19/2018 @ 11:36 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 3rd Quarter - Report | $1,095,000.00 | 2020 | 10/20/2020 @ 08:56 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 1st Quarter - Report | $1,074,000.00 | 2021 | 04/20/2021 @ 07:12 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4th Quarter - Report | $1,020,000.00 | 2021 | 01/20/2022 @ 03:34 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4th Quarter - Report | $876,000.00 | 2022 | 01/20/2023 @ 02:42 PM |
ASSOCIATION OF AMERICAN MEDICAL COLLEGES | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 3rd Quarter - Report | $912,077.00 | 2022 | 10/20/2022 @ 01:21 PM |
ASSOCIATION OF AMERICAN UNIVERSITIES | ASSOCIATION OF AMERICAN UNIVERSITIES | 4th Quarter - Report | $6,998.72 | 2010 | 01/20/2011 @ 01:59 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2018 | 05/22/2018 @ 11:51 AM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $590,000.00 | 2023 | 04/20/2023 @ 04:59 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $590,000.00 | 2022 | 01/20/2023 @ 03:27 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2023 | 04/10/2023 @ 01:53 PM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2023 | 04/10/2023 @ 01:53 PM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2023 | 04/10/2023 @ 01:53 PM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $770,000.00 | 2024 | 07/19/2024 @ 07:47 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $450,000.00 | 2021 | 01/20/2022 @ 05:35 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $500,000.00 | 2022 | 07/19/2022 @ 01:43 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $450,000.00 | 2021 | 10/20/2021 @ 02:37 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $450,000.00 | 2021 | 04/20/2021 @ 09:42 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $450,000.00 | 2020 | 01/21/2021 @ 06:49 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $550,000.00 | 2020 | 10/20/2020 @ 11:00 AM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $510,000.00 | 2020 | 07/17/2020 @ 04:01 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $270,000.00 | 2020 | 04/20/2020 @ 05:56 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $670,000.00 | 2019 | 01/21/2020 @ 05:26 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $410,000.00 | 2019 | 10/21/2019 @ 05:59 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $540,000.00 | 2019 | 04/22/2019 @ 01:59 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $460,000.00 | 2018 | 01/21/2019 @ 03:04 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $490,000.00 | 2018 | 07/20/2018 @ 04:40 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $560,000.00 | 2018 | 10/22/2018 @ 02:05 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2018 | 05/22/2018 @ 11:51 AM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2018 | 05/22/2018 @ 11:51 AM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $490,000.00 | 2017 | 01/22/2018 @ 03:45 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Amendment | $570,000.00 | 2017 | 12/14/2017 @ 07:20 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $430,000.00 | 2017 | 07/20/2017 @ 02:34 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $820,000.00 | 2017 | 04/20/2017 @ 01:56 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $740,000.00 | 2016 | 01/23/2017 @ 04:17 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $420,000.00 | 2016 | 10/20/2016 @ 03:16 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $450,000.00 | 2021 | 07/20/2021 @ 08:54 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $600,000.00 | 2017 | 10/20/2017 @ 01:41 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2018 | 05/22/2018 @ 11:51 AM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $340,000.00 | 2019 | 07/22/2019 @ 02:19 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2008 | 06/16/2022 @ 12:35 PM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $960,000.00 | 2024 | 04/22/2024 @ 04:46 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2008 | 06/16/2022 @ 12:35 PM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $440,000.00 | 2023 | 01/19/2024 @ 03:16 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $780,000.00 | 2018 | 04/20/2018 @ 04:09 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2008 | 06/16/2022 @ 12:35 PM | |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $620,000.00 | 2023 | 10/20/2023 @ 11:24 AM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $670,000.00 | 2024 | 10/18/2024 @ 01:29 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $590,000.00 | 2023 | 07/20/2023 @ 01:41 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $500,000.00 | 2022 | 04/20/2022 @ 06:04 PM |
ASTELLAS PHARMA US, INC. | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $520,000.00 | 2022 | 10/20/2022 @ 02:48 PM |
BIOCOM | BIOCOM | 3rd Quarter - Amendment | $45,000.00 | 2020 | 11/17/2020 @ 03:40 PM |
BIOCOM | BIOCOM | 4th Quarter - Report | $75,000.00 | 2022 | 01/20/2023 @ 11:03 AM |
BIOCOM | BIOCOM | 3rd Quarter - Report | $75,000.00 | 2022 | 10/19/2022 @ 11:27 AM |
BIOCOM | BIOCOM | 2nd Quarter - Report | $75,000.00 | 2023 | 07/18/2023 @ 12:54 PM |
BIOCOM | BIOCOM | 3rd Quarter - Report | $75,000.00 | 2024 | 10/22/2024 @ 01:49 PM |
BIOCOM | BIOCOM | 4th Quarter - Report | $45,000.00 | 2020 | 02/10/2021 @ 04:54 PM |
BIOCOM | BIOCOM | 3rd Quarter - Report | $75,000.00 | 2023 | 10/20/2023 @ 11:48 AM |
BIOCOM | BIOCOM | 2nd Quarter - Report | $75,000.00 | 2024 | 07/22/2024 @ 03:47 PM |
BIOCOM | BIOCOM | 1st Quarter - Report | $75,000.00 | 2023 | 04/20/2023 @ 05:55 PM |
BIOCOM | BIOCOM | 1st Quarter - Report | $75,000.00 | 2024 | 04/22/2024 @ 02:44 PM |
BIOCOM | BIOCOM | 1st Quarter - Report | $70,000.00 | 2020 | 04/06/2020 @ 05:00 PM |
BIOCOM | BIOCOM | 3rd Quarter - Report | $45,000.00 | 2020 | 11/17/2020 @ 11:12 AM |
BIOCOM | BIOCOM | 2nd Quarter - Report | $75,000.00 | 2022 | 07/18/2022 @ 02:28 PM |
BIOCOM | BIOCOM | 1st Quarter - Report | $75,000.00 | 2022 | 04/19/2022 @ 02:50 PM |
BIOCOM | BIOCOM | 4th Quarter - Report | $75,000.00 | 2023 | 01/22/2024 @ 04:19 PM |
BIOCOM | BIOCOM | 2nd Quarter - Report | $45,000.00 | 2020 | 08/07/2020 @ 04:07 PM |
BIOGEN | BIOGEN | 2nd Quarter - Report | $1,670,000.00 | 2024 | 07/22/2024 @ 11:43 AM |
BIOGEN | BIOGEN | 3rd Quarter - Report | $710,000.00 | 2024 | 10/19/2024 @ 03:44 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Amendment | $1,740,000.00 | 2012 | 11/13/2012 @ 04:53 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $1,680,000.00 | 2024 | 10/21/2024 @ 03:05 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Amendment | $3,320,000.00 | 2020 | 04/06/2022 @ 06:34 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $1,790,000.00 | 2024 | 07/22/2024 @ 11:04 AM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Amendment | $1,760,000.00 | 2024 | 04/26/2024 @ 04:06 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $1,760,000.00 | 2024 | 04/22/2024 @ 10:27 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $2,200,000.00 | 2023 | 01/22/2024 @ 06:37 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $2,200,000.00 | 2023 | 10/20/2023 @ 04:53 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Amendment | $3,120,000.00 | 2019 | 03/26/2024 @ 01:10 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $2,200,000.00 | 2023 | 07/20/2023 @ 12:58 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Amendment | $2,200,000.00 | 2023 | 09/26/2023 @ 02:26 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $2,430,000.00 | 2023 | 04/20/2023 @ 01:01 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $3,740,000.00 | 2022 | 01/19/2023 @ 10:23 AM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $3,370,000.00 | 2021 | 01/19/2022 @ 05:22 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Amendment | $3,320,000.00 | 2020 | 11/04/2021 @ 01:22 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $3,500,000.00 | 2021 | 07/20/2021 @ 10:14 AM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $3,060,000.00 | 2021 | 04/20/2021 @ 12:23 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $3,180,000.00 | 2020 | 01/20/2021 @ 02:00 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $3,170,000.00 | 2020 | 10/20/2020 @ 07:12 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $2,890,000.00 | 2020 | 04/20/2020 @ 06:13 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $3,120,000.00 | 2019 | 01/21/2020 @ 05:16 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $3,080,000.00 | 2019 | 10/21/2019 @ 01:40 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $3,360,000.00 | 2021 | 10/20/2021 @ 09:59 AM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $3,010,000.00 | 2019 | 07/22/2019 @ 04:49 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $3,000,000.00 | 2019 | 04/22/2019 @ 07:41 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $2,500,000.00 | 2018 | 01/22/2019 @ 04:07 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $2,480,000.00 | 2018 | 10/22/2018 @ 04:39 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $2,520,000.00 | 2018 | 07/20/2018 @ 03:23 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $2,370,000.00 | 2018 | 04/20/2018 @ 04:46 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $2,360,000.00 | 2017 | 01/22/2018 @ 04:59 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $2,380,000.00 | 2017 | 10/20/2017 @ 05:11 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $2,300,000.00 | 2017 | 04/20/2017 @ 05:21 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $2,330,000.00 | 2016 | 01/23/2017 @ 06:07 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $2,310,000.00 | 2016 | 07/20/2016 @ 09:52 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $2,260,000.00 | 2016 | 04/20/2016 @ 09:59 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $2,110,000.00 | 2015 | 01/20/2016 @ 08:42 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $3,320,000.00 | 2020 | 07/20/2020 @ 06:56 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $1,740,000.00 | 2012 | 10/22/2012 @ 04:00 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $2,030,000.00 | 2011 | 01/20/2012 @ 05:47 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $1,980,000.00 | 2011 | 10/20/2011 @ 05:22 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $3,120,000.00 | 2022 | 07/18/2022 @ 03:55 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $2,100,000.00 | 2010 | 01/20/2011 @ 08:00 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $2,020,000.00 | 2010 | 07/20/2010 @ 06:10 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $2,200,000.00 | 2010 | 04/20/2010 @ 05:31 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $3,170,000.00 | 2022 | 04/20/2022 @ 07:49 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 4th Quarter - Report | $1,860,000.00 | 2009 | 01/20/2010 @ 05:17 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $1,780,000.00 | 2009 | 10/20/2009 @ 05:39 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Amendment | $1,920,000.00 | 2008 | 08/19/2009 @ 12:28 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $1,800,000.00 | 2009 | 07/20/2009 @ 05:08 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $1,920,000.00 | 2008 | 10/20/2008 @ 06:01 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2nd Quarter - Report | $1,920,000.00 | 2008 | 07/21/2008 @ 06:55 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Amendment | $1,920,000.00 | 2008 | 05/20/2008 @ 11:09 AM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Amendment | $1,920,000.00 | 2008 | 05/20/2008 @ 10:56 AM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $1,920,000.00 | 2008 | 04/21/2008 @ 04:27 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | Year-End Amendment | $3,560,000.00 | 2007 | 03/12/2008 @ 04:27 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | Mid-Year Report | $3,600,000.00 | 2007 | 08/14/2007 @ 01:58 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $2,120,000.00 | 2010 | 10/20/2010 @ 07:00 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 1st Quarter - Report | $2,000,000.00 | 2011 | 04/20/2011 @ 05:53 PM |
BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | 3rd Quarter - Report | $3,220,000.00 | 2022 | 10/20/2022 @ 01:07 PM |
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | 3rd Quarter - Amendment | $490,000.00 | 2019 | 08/04/2020 @ 05:23 PM |
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | 2nd Quarter - Report | $840,000.00 | 2020 | 07/20/2020 @ 03:46 PM |
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | 4th Quarter - Report | $515,000.00 | 2019 | 01/21/2020 @ 04:21 PM |
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | 2nd Quarter - Report | $750,000.00 | 2019 | 07/22/2019 @ 03:02 PM |
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | 1st Quarter - Report | $860,000.00 | 2019 | 04/22/2019 @ 02:42 PM |
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | 1st Quarter - Report | $925,000.00 | 2020 | 04/20/2020 @ 10:27 AM |
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | 3rd Quarter - Report | $490,000.00 | 2019 | 10/21/2019 @ 11:28 AM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 2nd Quarter - Report | $110,000.00 | 2017 | 07/20/2017 @ 04:22 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 1st Quarter - Report | $160,000.00 | 2017 | 06/05/2017 @ 01:38 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 1st Quarter - Report | $135,000.00 | 2021 | 04/20/2021 @ 06:26 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 4th Quarter - Report | $140,000.00 | 2017 | 01/19/2018 @ 08:10 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 3rd Quarter - Report | $120,000.00 | 2018 | 10/19/2018 @ 08:59 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 2nd Quarter - Report | $150,000.00 | 2018 | 07/20/2018 @ 02:39 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 1st Quarter - Report | $340,000.00 | 2016 | 04/19/2016 @ 02:19 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 2nd Quarter - Report | $240,000.00 | 2016 | 07/19/2016 @ 01:22 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 3rd Quarter - Report | $270,000.00 | 2016 | 10/19/2016 @ 03:14 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 4th Quarter - Report | $190,000.00 | 2016 | 01/20/2017 @ 02:01 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 3rd Quarter - Report | $230,000.00 | 2024 | 10/19/2024 @ 04:19 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 3rd Quarter - Report | $120,000.00 | 2017 | 10/20/2017 @ 12:50 PM |
CALIFORNIA LIFE SCIENCES | CALIFORNIA LIFE SCIENCES | 1st Quarter - Report | $130,000.00 | 2018 | 04/20/2018 @ 07:23 PM |
CASE WESTERN RESERVE UNIVERSITY | CASE WESTERN RESERVE UNIVERSITY | 1st Quarter - Report | $134,000.00 | 2024 | 04/19/2024 @ 01:34 PM |
CASE WESTERN RESERVE UNIVERSITY | CASE WESTERN RESERVE UNIVERSITY | 2nd Quarter - Report | $130,000.00 | 2024 | 07/18/2024 @ 12:40 PM |
CASE WESTERN RESERVE UNIVERSITY | CASE WESTERN RESERVE UNIVERSITY | 3rd Quarter - Report | $110,000.00 | 2024 | 10/18/2024 @ 10:17 AM |
CENTER FOR INDIVIDUAL FREEDOM | CENTER FOR INDIVIDUAL FREEDOM | 1st Quarter - Report | $10,000.00 | 2022 | 04/18/2022 @ 02:21 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 2nd Quarter - Report | $16,390,000.00 | 2023 | 07/20/2023 @ 12:51 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 1st Quarter - Report | $18,660,000.00 | 2023 | 04/20/2023 @ 02:15 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 1st Quarter - Report | $18,660,000.00 | 2023 | 04/20/2023 @ 02:15 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 1st Quarter - Amendment | $18,660,000.00 | 2023 | 04/20/2023 @ 04:19 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 1st Quarter - Amendment | $18,660,000.00 | 2023 | 04/20/2023 @ 04:19 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 2nd Quarter - Report | $16,390,000.00 | 2023 | 07/20/2023 @ 12:51 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 2nd Quarter - Report | $16,390,000.00 | 2023 | 07/20/2023 @ 12:51 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 3rd Quarter - Report | $13,590,000.00 | 2023 | 10/20/2023 @ 10:17 AM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 3rd Quarter - Report | $13,590,000.00 | 2023 | 10/20/2023 @ 10:17 AM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 4th Quarter - Report | $19,080,000.00 | 2023 | 01/22/2024 @ 01:04 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 4th Quarter - Report | $19,080,000.00 | 2023 | 01/22/2024 @ 01:04 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 1st Quarter - Report | $23,370,000.00 | 2024 | 04/22/2024 @ 12:51 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 1st Quarter - Report | $23,370,000.00 | 2024 | 04/22/2024 @ 12:51 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 2nd Quarter - Report | $13,930,000.00 | 2024 | 07/22/2024 @ 02:27 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 2nd Quarter - Report | $13,930,000.00 | 2024 | 07/22/2024 @ 02:27 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 3rd Quarter - Report | $14,750,000.00 | 2024 | 10/21/2024 @ 12:47 PM |
CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | 3rd Quarter - Report | $14,750,000.00 | 2024 | 10/21/2024 @ 12:47 PM |
COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | 3rd Quarter - Amendment | $50,000.00 | 2024 | 10/21/2024 @ 02:17 PM |
COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | 4th Quarter - Report | $50,000.00 | 2023 | 01/22/2024 @ 11:02 AM |
COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | 2nd Quarter - Report | $50,000.00 | 2023 | 07/20/2023 @ 11:07 AM |
COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | 3rd Quarter - Report | $50,000.00 | 2023 | 10/20/2023 @ 10:50 AM |
COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | 1st Quarter - Report | $50,000.00 | 2024 | 04/22/2024 @ 11:07 AM |
COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | 2nd Quarter - Report | $50,000.00 | 2024 | 07/22/2024 @ 12:47 PM |
COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | 3rd Quarter - Report | $50,000.00 | 2024 | 10/21/2024 @ 01:09 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 4th Quarter - Report | $100,000.00 | 2022 | 01/20/2023 @ 10:41 AM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 2nd Quarter - Report | $480,000.00 | 2021 | 07/20/2021 @ 05:57 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 4th Quarter - Report | $170,000.00 | 2020 | 01/21/2021 @ 08:00 AM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 4th Quarter - Report | $200,000.00 | 2017 | 01/22/2018 @ 01:36 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 3rd Quarter - Report | $330,000.00 | 2017 | 10/20/2017 @ 04:17 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 1st Quarter - Report | $140,000.00 | 2023 | 04/20/2023 @ 03:02 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 2nd Quarter - Report | $430,000.00 | 2017 | 07/20/2017 @ 03:50 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 2nd Quarter - Report | $420,000.00 | 2020 | 07/20/2020 @ 03:46 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 3rd Quarter - Report | $350,000.00 | 2020 | 10/20/2020 @ 04:27 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 1st Quarter - Report | $380,000.00 | 2021 | 04/20/2021 @ 03:02 PM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 2nd Quarter - Report | $140,000.00 | 2023 | 07/20/2023 @ 10:22 AM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 3rd Quarter - Report | $290,000.00 | 2024 | 10/21/2024 @ 11:42 AM |
COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | 1st Quarter - Report | $310,000.00 | 2018 | 04/18/2018 @ 05:05 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 3rd Quarter - Report | $30,000.00 | 2020 | 10/17/2020 @ 07:45 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 2nd Quarter - Report | $40,000.00 | 2021 | 07/18/2021 @ 10:07 AM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 1st Quarter - Report | $40,000.00 | 2024 | 04/22/2024 @ 05:37 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 1st Quarter - Report | $40,000.00 | 2023 | 04/20/2023 @ 10:18 AM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 2nd Quarter - Report | $40,000.00 | 2024 | 07/20/2024 @ 06:30 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 4th Quarter - Report | $40,000.00 | 2023 | 01/20/2024 @ 04:16 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 3rd Quarter - Report | $40,000.00 | 2022 | 10/20/2022 @ 10:15 AM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 4th Quarter - Report | $40,000.00 | 2021 | 01/19/2022 @ 10:21 AM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 2nd Quarter - Report | $40,000.00 | 2023 | 07/19/2023 @ 07:14 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 3rd Quarter - Report | $40,000.00 | 2021 | 10/19/2021 @ 02:43 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 1st Quarter - Report | $40,000.00 | 2022 | 04/19/2022 @ 01:07 AM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 4th Quarter - Report | $40,000.00 | 2022 | 01/20/2023 @ 10:00 AM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 3rd Quarter - Report | $40,000.00 | 2023 | 10/20/2023 @ 03:34 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 4th Quarter - Report | $30,000.00 | 2020 | 01/20/2021 @ 12:17 AM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 2nd Quarter - Report | $40,000.00 | 2022 | 07/20/2022 @ 01:45 PM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 1st Quarter - Report | $40,000.00 | 2021 | 04/19/2021 @ 08:17 AM |
CROSSROADS STRATEGIES, LLC | BRISTOL-MYERS SQUIBB | 3rd Quarter - Report | $40,000.00 | 2024 | 10/20/2024 @ 09:22 AM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 3rd Quarter - Report | $50,000.00 | 2022 | 10/19/2022 @ 06:28 PM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 2nd Quarter - Report | $50,000.00 | 2021 | 07/18/2021 @ 10:18 AM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 1st Quarter - Report | $50,000.00 | 2022 | 04/19/2022 @ 09:16 AM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 2nd Quarter - Report | $50,000.00 | 2022 | 07/20/2022 @ 09:33 AM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 1st Quarter - Report | $50,000.00 | 2021 | 04/19/2021 @ 09:42 AM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 3rd Quarter - Report | $50,000.00 | 2020 | 10/17/2020 @ 09:29 PM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 4th Quarter - Termination | $50,000.00 | 2022 | 01/20/2023 @ 05:51 PM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 4th Quarter - Report | $50,000.00 | 2020 | 01/20/2021 @ 12:36 AM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 3rd Quarter - Report | $50,000.00 | 2021 | 10/19/2021 @ 03:02 PM |
CROSSROADS STRATEGIES, LLC | GENENTECH, INC. | 4th Quarter - Report | $50,000.00 | 2021 | 01/19/2022 @ 10:44 AM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 2nd Quarter - Report | $40,000.00 | 2022 | 07/20/2022 @ 01:55 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 4th Quarter - Report | $40,000.00 | 2023 | 01/22/2024 @ 11:41 AM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 2nd Quarter - Report | $40,000.00 | 2024 | 07/22/2024 @ 05:31 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 1st Quarter - Report | $40,000.00 | 2021 | 04/20/2021 @ 04:10 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 1st Quarter - Report | $40,000.00 | 2024 | 04/22/2024 @ 01:45 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 4th Quarter - Report | $40,000.00 | 2022 | 01/20/2023 @ 10:03 AM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 3rd Quarter - Report | $40,000.00 | 2023 | 10/20/2023 @ 01:45 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 1st Quarter - Report | $40,000.00 | 2022 | 04/20/2022 @ 11:20 AM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 3rd Quarter - Report | $40,000.00 | 2021 | 10/19/2021 @ 03:44 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 1st Quarter - Report | $40,000.00 | 2023 | 04/20/2023 @ 01:10 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 2nd Quarter - Report | $40,000.00 | 2023 | 07/20/2023 @ 03:18 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 3rd Quarter - Report | $40,000.00 | 2020 | 10/20/2020 @ 09:20 AM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 3rd Quarter - Report | $40,000.00 | 2024 | 10/20/2024 @ 12:00 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 4th Quarter - Report | $40,000.00 | 2021 | 01/19/2022 @ 05:22 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 2nd Quarter - Report | $40,000.00 | 2021 | 07/19/2021 @ 11:07 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 3rd Quarter - Report | $40,000.00 | 2022 | 10/19/2022 @ 08:18 PM |
CROSSROADS STRATEGIES, LLC | MERCK & CO., INC. | 4th Quarter - Report | $40,000.00 | 2020 | 01/20/2021 @ 03:00 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $60,000.00 | 2021 | 07/18/2021 @ 10:54 AM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $60,000.00 | 2022 | 04/19/2022 @ 10:56 AM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $60,000.00 | 2022 | 01/19/2023 @ 05:51 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $60,000.00 | 2021 | 01/19/2022 @ 12:57 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $60,000.00 | 2022 | 07/20/2022 @ 11:17 AM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $60,000.00 | 2021 | 10/19/2021 @ 07:35 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $60,000.00 | 2022 | 10/19/2022 @ 11:49 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $60,000.00 | 2024 | 07/20/2024 @ 07:19 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $60,000.00 | 2023 | 10/20/2023 @ 02:33 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $50,000.00 | 2020 | 01/20/2021 @ 03:35 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $60,000.00 | 2024 | 04/22/2024 @ 03:46 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $60,000.00 | 2023 | 01/20/2024 @ 04:40 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $60,000.00 | 2023 | 04/19/2023 @ 01:54 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $60,000.00 | 2023 | 07/19/2023 @ 08:07 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $60,000.00 | 2024 | 10/20/2024 @ 12:52 PM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $50,000.00 | 2020 | 10/18/2020 @ 10:32 AM |
CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $60,000.00 | 2021 | 04/19/2021 @ 11:07 AM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 1st Quarter - Report | $50,000.00 | 2024 | 04/22/2024 @ 02:59 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 2nd Quarter - Report | $50,000.00 | 2021 | 07/18/2021 @ 12:15 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 3rd Quarter - Report | $50,000.00 | 2022 | 10/20/2022 @ 09:51 AM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 4th Quarter - Report | $50,000.00 | 2020 | 01/20/2021 @ 04:51 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 3rd Quarter - Report | $50,000.00 | 2020 | 10/18/2020 @ 10:51 AM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 1st Quarter - Report | $50,000.00 | 2021 | 04/19/2021 @ 11:13 AM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 2nd Quarter - Report | $50,000.00 | 2022 | 07/20/2022 @ 11:35 AM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 2nd Quarter - Report | $50,000.00 | 2024 | 07/20/2024 @ 07:24 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 4th Quarter - Report | $50,000.00 | 2023 | 01/20/2024 @ 04:49 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 2nd Quarter - Report | $50,000.00 | 2023 | 07/19/2023 @ 08:14 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 1st Quarter - Report | $50,000.00 | 2022 | 04/19/2022 @ 11:24 AM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 4th Quarter - Report | $50,000.00 | 2021 | 01/19/2022 @ 01:05 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 3rd Quarter - Report | $50,000.00 | 2021 | 10/19/2021 @ 09:58 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 3rd Quarter - Report | $50,000.00 | 2023 | 10/20/2023 @ 02:51 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 1st Quarter - Report | $50,000.00 | 2023 | 04/19/2023 @ 02:12 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 4th Quarter - Report | $50,000.00 | 2022 | 01/19/2023 @ 06:20 PM |
CROSSROADS STRATEGIES, LLC | SANOFI US SERVICES INC. | 3rd Quarter - Report | $50,000.00 | 2024 | 10/20/2024 @ 01:55 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 1st Quarter - Report | $40,000.00 | 2023 | 04/20/2023 @ 07:10 AM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 3rd Quarter - Report | $30,000.00 | 2020 | 10/17/2020 @ 08:18 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 4th Quarter - Report | $30,000.00 | 2020 | 01/20/2021 @ 12:20 AM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 2nd Quarter - Report | $40,000.00 | 2021 | 07/18/2021 @ 11:11 AM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 3rd Quarter - Report | $40,000.00 | 2024 | 10/21/2024 @ 11:00 AM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 4th Quarter - Report | $40,000.00 | 2022 | 01/19/2023 @ 06:45 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 2nd Quarter - Report | $40,000.00 | 2023 | 07/19/2023 @ 08:28 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 1st Quarter - Report | $40,000.00 | 2024 | 04/22/2024 @ 02:35 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 3rd Quarter - Report | $40,000.00 | 2021 | 10/19/2021 @ 02:46 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 4th Quarter - Report | $40,000.00 | 2023 | 01/20/2024 @ 05:11 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 2nd Quarter - Report | $40,000.00 | 2022 | 07/20/2022 @ 01:46 AM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 1st Quarter - Report | $40,000.00 | 2022 | 04/19/2022 @ 01:10 AM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 2nd Quarter - Report | $40,000.00 | 2024 | 07/22/2024 @ 05:35 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 3rd Quarter - Report | $40,000.00 | 2022 | 10/19/2022 @ 06:05 PM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 4th Quarter - Report | $40,000.00 | 2021 | 01/19/2022 @ 10:23 AM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 1st Quarter - Report | $30,000.00 | 2021 | 04/19/2021 @ 11:22 AM |
CROSSROADS STRATEGIES, LLC | TAKEDA PHARMACEUTICALS AMERICA, INC. | 3rd Quarter - Report | $40,000.00 | 2023 | 10/20/2023 @ 10:31 AM |
CROWELL GLOBAL ADVISORS (FKA CROWELL & MORING INTERNATIONAL, LLC) | BAYH-DOLE COALITION | 3rd Quarter - Report | $20,000.00 | 2024 | 10/21/2024 @ 12:44 PM |
CROWELL GLOBAL ADVISORS (FKA CROWELL & MORING INTERNATIONAL, LLC) | BAYH-DOLE COALITION | Registration | 2024 | 08/30/2024 @ 09:54 AM | |
DAIICHI SANKYO, INC. | DAIICHI SANKYO INC | 1st Quarter - Report | $190,000.00 | 2016 | 04/19/2016 @ 09:42 PM |
DAVE KOLBE CONSULTING | PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | 1st Quarter - Report | $30,000.00 | 2024 | 04/10/2024 @ 08:30 PM |
EISAI INC. | EISAI INC. | 1st Quarter - Report | $320,000.00 | 2022 | 04/20/2022 @ 03:52 PM |
EISAI INC. | EISAI INC. | Registration - Amendment | 2022 | 03/30/2022 @ 02:40 PM | |
EISAI INC. | EISAI INC. | 4th Quarter - Report | $530,000.00 | 2022 | 01/20/2023 @ 09:59 AM |
EISAI INC. | EISAI INC. | Registration - Amendment | 2022 | 03/30/2022 @ 02:40 PM | |
EISAI INC. | EISAI INC. | Registration - Amendment | 2022 | 03/30/2022 @ 02:40 PM | |
EISAI INC. | EISAI INC. | 3rd Quarter - Report | $530,000.00 | 2022 | 10/20/2022 @ 10:18 AM |
EISAI INC. | EISAI INC. | 2nd Quarter - Report | $360,000.00 | 2022 | 07/20/2022 @ 10:12 AM |
ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | Registration | 2024 | 10/09/2024 @ 05:21 PM | |
ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | Registration | 2024 | 10/09/2024 @ 05:21 PM | |
ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | Registration | 2024 | 10/09/2024 @ 05:21 PM | |
ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | Registration | 2024 | 10/09/2024 @ 05:21 PM | |
ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | Registration | 2024 | 10/09/2024 @ 05:21 PM | |
ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | Registration | 2024 | 10/09/2024 @ 05:21 PM | |
ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | Registration | 2024 | 10/09/2024 @ 05:21 PM | |
ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | Registration | 2024 | 10/09/2024 @ 05:21 PM | |
FAEGRE DRINKER BIDDLE & REATH LLP | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 4th Quarter - Report | 2009 | 01/19/2010 @ 04:31 PM | |
FAEGRE DRINKER BIDDLE & REATH LLP | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 1st Quarter - Report | 2010 | 04/16/2010 @ 11:41 AM | |
FAEGRE DRINKER BIDDLE & REATH LLP | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2nd Quarter - Report | 2010 | 07/19/2010 @ 11:28 AM | |
FAEGRE DRINKER BIDDLE & REATH LLP | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 3rd Quarter - Report | 2009 | 10/20/2009 @ 03:15 PM | |
FAEGRE DRINKER BIDDLE & REATH LLP | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 3rd Quarter - Report | 2010 | 10/20/2010 @ 09:54 AM | |
FAEGRE DRINKER BIDDLE & REATH LLP | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 4th Quarter - Report | $10,000.00 | 2010 | 01/20/2011 @ 03:51 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 3rd Quarter - Report | $60,000.00 | 2011 | 10/18/2011 @ 01:28 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Report | $60,000.00 | 2014 | 04/16/2014 @ 02:57 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 3rd Quarter - Report | $60,000.00 | 2013 | 10/17/2013 @ 10:28 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 4th Quarter - Report | $60,000.00 | 2011 | 01/17/2012 @ 04:50 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 3rd Quarter - Report | $60,000.00 | 2012 | 10/22/2012 @ 03:07 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 4th Quarter - Report | $60,000.00 | 2013 | 01/20/2014 @ 03:36 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 3rd Quarter - Report | $30,000.00 | 2016 | 10/14/2016 @ 10:36 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Report | $30,000.00 | 2016 | 04/14/2016 @ 04:19 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 3rd Quarter - Report | $30,000.00 | 2015 | 10/16/2015 @ 02:29 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 4th Quarter - Report | $30,000.00 | 2015 | 01/13/2016 @ 11:54 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2nd Quarter - Report | $30,000.00 | 2015 | 07/16/2015 @ 12:06 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 4th Quarter - Report | $60,000.00 | 2014 | 01/14/2015 @ 03:38 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2nd Quarter - Report | $60,000.00 | 2014 | 07/17/2014 @ 01:33 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Report | $60,000.00 | 2013 | 04/22/2013 @ 03:05 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2nd Quarter - Report | $60,000.00 | 2013 | 07/19/2013 @ 01:18 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 4th Quarter - Report | $60,000.00 | 2012 | 01/18/2013 @ 03:22 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Report | $60,000.00 | 2012 | 04/19/2012 @ 03:39 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2nd Quarter - Report | $60,000.00 | 2012 | 07/20/2012 @ 10:39 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2nd Quarter - Report | $60,000.00 | 2010 | 07/19/2010 @ 11:10 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Report | $60,000.00 | 2010 | 04/20/2010 @ 10:20 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 4th Quarter - Report | $60,000.00 | 2009 | 01/20/2010 @ 10:39 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Report | $30,000.00 | 2015 | 04/09/2015 @ 12:57 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 3rd Quarter - Report | $60,000.00 | 2014 | 10/17/2014 @ 12:39 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 4th Quarter - Report | $30,000.00 | 2016 | 01/12/2017 @ 04:05 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Report | $30,000.00 | 2017 | 04/13/2017 @ 10:59 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Amendment | $20,000.00 | 2017 | 07/20/2017 @ 12:36 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | Year-End Report | $30,000.00 | 2006 | 02/12/2007 @ 04:09 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 3rd Quarter - Report | $40,000.00 | 2009 | 10/20/2009 @ 03:27 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2nd Quarter - Report | $30,000.00 | 2009 | 07/20/2009 @ 01:10 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 3rd Quarter - Report | $60,000.00 | 2010 | 10/20/2010 @ 09:56 AM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 4th Quarter - Report | $60,000.00 | 2010 | 01/20/2011 @ 03:45 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 1st Quarter - Report | $60,000.00 | 2011 | 04/20/2011 @ 03:09 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2nd Quarter - Report | $30,000.00 | 2016 | 07/18/2016 @ 03:48 PM |
FAEGRE DRINKER BIDDLE & REATH LLP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2nd Quarter - Report | $60,000.00 | 2011 | 07/20/2011 @ 11:28 AM |
GEORGIA INSTITUTE OF TECHNOLOGY | GEORGIA INSTITUTE OF TECHNOLOGY | 4th Quarter - Report | $50,000.00 | 2010 | 01/19/2011 @ 12:39 PM |
GRIZZLE COMPANY | UNIVERSITY OF LOUISVILLE | 3rd Quarter - Report | $30,000.00 | 2017 | 10/04/2017 @ 03:31 PM |
GRIZZLE COMPANY | UNIVERSITY OF LOUISVILLE | 4th Quarter - Report | $30,000.00 | 2017 | 01/19/2018 @ 05:11 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $920,000.00 | 2018 | 01/22/2019 @ 06:07 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $1,500,000.00 | 2023 | 01/22/2024 @ 06:38 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,490,000.00 | 2019 | 04/22/2019 @ 08:31 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $870,000.00 | 2019 | 07/22/2019 @ 05:42 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $700,000.00 | 2019 | 01/21/2020 @ 08:55 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $940,000.00 | 2020 | 04/20/2020 @ 09:52 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $870,000.00 | 2020 | 07/20/2020 @ 07:29 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,400,000.00 | 2018 | 07/20/2018 @ 06:08 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,210,000.00 | 2020 | 10/20/2020 @ 08:04 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $1,000,000.00 | 2021 | 01/20/2022 @ 07:17 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,700,000.00 | 2023 | 04/20/2023 @ 10:38 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,110,000.00 | 2022 | 07/20/2022 @ 05:19 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $750,000.00 | 2020 | 01/20/2021 @ 09:50 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $650,000.00 | 2017 | 10/20/2017 @ 05:35 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $780,000.00 | 2017 | 07/20/2017 @ 09:22 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,510,000.00 | 2024 | 07/22/2024 @ 09:44 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $830,000.00 | 2022 | 04/20/2022 @ 06:37 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Amendment | $1,000,000.00 | 2021 | 10/21/2022 @ 11:47 AM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,390,000.00 | 2022 | 10/20/2022 @ 11:17 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,640,000.00 | 2017 | 04/20/2017 @ 10:30 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,130,000.00 | 2018 | 10/22/2018 @ 05:47 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $860,000.00 | 2022 | 01/20/2023 @ 03:16 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $492,000.00 | 2016 | 01/23/2017 @ 07:51 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,360,000.00 | 2019 | 10/21/2019 @ 04:53 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $640,000.00 | 2016 | 10/20/2016 @ 06:32 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,070,000.00 | 2016 | 07/20/2016 @ 04:23 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,490,000.00 | 2016 | 04/20/2016 @ 07:19 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,540,000.00 | 2024 | 10/21/2024 @ 05:39 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $820,000.00 | 2024 | 04/22/2024 @ 08:07 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,300,000.00 | 2021 | 07/20/2021 @ 01:27 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,200,000.00 | 2021 | 10/20/2021 @ 05:02 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,800,000.00 | 2021 | 04/20/2021 @ 11:59 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,030,000.00 | 2023 | 10/20/2023 @ 04:19 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Amendment | $1,100,000.00 | 2022 | 04/29/2022 @ 02:06 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $900,000.00 | 2023 | 07/20/2023 @ 06:14 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,110,000.00 | 2018 | 04/20/2018 @ 04:32 PM |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $1,110,000.00 | 2017 | 01/22/2018 @ 05:34 PM |
HP INC. | HP INC | 4th Quarter - Report | $1,350,000.00 | 2008 | 01/15/2009 @ 04:37 PM |
HP INC. | HP INC | Year-End Report | $980,000.00 | 2007 | 02/14/2008 @ 05:09 PM |
HP INC. | HP INC | 2nd Quarter - Report | $450,000.00 | 2008 | 07/18/2008 @ 11:53 AM |
HP INC. | HP INC | 3rd Quarter - Report | $760,000.00 | 2008 | 10/17/2008 @ 10:47 AM |
HP INC. | HP INC | Mid-Year Report | $1,000,000.00 | 2007 | 08/10/2007 @ 04:40 PM |
HP INC. | HP INC | 2nd Quarter - Report | $450,000.00 | 2008 | 07/18/2008 @ 11:53 AM |
HP INC. | HP INC | 3rd Quarter - Report | $760,000.00 | 2008 | 10/17/2008 @ 10:47 AM |
HP INC. | HP INC | 1st Quarter - Report | $400,000.00 | 2008 | 04/18/2008 @ 03:20 PM |
HP INC. | HP INC | 1st Quarter - Report | $400,000.00 | 2008 | 04/18/2008 @ 03:20 PM |
HP INC. | HP INC | Year-End Report | $980,000.00 | 2007 | 02/14/2008 @ 05:09 PM |
HP INC. | HP INC | Mid-Year Report | $1,000,000.00 | 2007 | 08/10/2007 @ 04:40 PM |
HP INC. | HP INC | 4th Quarter - Report | $1,350,000.00 | 2008 | 01/15/2009 @ 04:37 PM |
INDIANA UNIVERSITY | INDIANA UNIVERSITY | 1st Quarter - Report | $100,000.00 | 2009 | 04/20/2009 @ 04:47 PM |
INTEL CORPORATION | INTEL CORPORATION | 2nd Quarter - Report | $2,010,000.00 | 2024 | 07/19/2024 @ 05:24 PM |
INTEL CORPORATION | INTEL CORPORATION | 3rd Quarter - Report | $1,600,000.00 | 2024 | 10/21/2024 @ 03:43 PM |
IOWA STATE UNIVERSITY | IOWA STATE UNIVERSITY | 3rd Quarter - Report | $47,449.76 | 2008 | 10/20/2008 @ 12:16 PM |
IOWA STATE UNIVERSITY | IOWA STATE UNIVERSITY | 1st Quarter - Report | $62,701.87 | 2008 | 04/18/2008 @ 03:20 PM |
IOWA STATE UNIVERSITY | IOWA STATE UNIVERSITY | 2nd Quarter - Report | $57,653.24 | 2008 | 07/17/2008 @ 10:05 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 1st Quarter - Report | 2018 | 04/06/2018 @ 06:50 PM | |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 3rd Quarter - Report | $64,000.00 | 2023 | 10/09/2023 @ 10:14 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 3rd Quarter - Report | $10,000.00 | 2017 | 10/06/2017 @ 02:00 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 1st Quarter - Report | $30,000.00 | 2022 | 04/04/2022 @ 11:17 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 3rd Quarter - Termination | $53,000.00 | 2024 | 10/09/2024 @ 10:39 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 3rd Quarter - Termination | $53,000.00 | 2024 | 10/09/2024 @ 10:37 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 4th Quarter - Report | 2018 | 01/12/2019 @ 06:40 PM | |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 1st Quarter - Report | $40,000.00 | 2019 | 04/06/2019 @ 02:02 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 4th Quarter - Amendment | 2018 | 04/06/2019 @ 03:02 PM | |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 4th Quarter - Report | $80,000.00 | 2017 | 01/12/2018 @ 03:39 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 2nd Quarter - Report | $10,000.00 | 2018 | 07/06/2018 @ 10:58 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 3rd Quarter - Report | $10,000.00 | 2018 | 10/12/2018 @ 09:57 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 2nd Quarter - Report | $20,000.00 | 2019 | 07/12/2019 @ 04:40 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 3rd Quarter - Report | 2019 | 10/14/2019 @ 02:24 PM | |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 4th Quarter - Report | $10,000.00 | 2020 | 01/09/2021 @ 10:44 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 4th Quarter - Report | $10,000.00 | 2019 | 01/11/2020 @ 12:48 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 1st Quarter - Report | $60,000.00 | 2020 | 04/13/2020 @ 02:37 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 2nd Quarter - Report | $10,000.00 | 2020 | 07/06/2020 @ 09:07 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 4th Quarter - Report | $10,000.00 | 2022 | 01/03/2023 @ 08:11 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 2nd Quarter - Report | $19,000.00 | 2024 | 07/03/2024 @ 10:57 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 3rd Quarter - Report | $20,000.00 | 2020 | 10/09/2020 @ 10:03 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 4th Quarter - Report | $10,000.00 | 2021 | 01/14/2022 @ 01:57 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 1st Quarter - Report | $10,000.00 | 2024 | 04/05/2024 @ 10:13 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 3rd Quarter - Report | $10,000.00 | 2022 | 10/05/2022 @ 04:58 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 4th Quarter - Report | $10,000.00 | 2023 | 01/09/2024 @ 11:42 AM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 2nd Quarter - Report | $60,000.00 | 2022 | 07/02/2022 @ 12:51 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 1st Quarter - Report | $22,875.00 | 2023 | 04/12/2023 @ 04:01 PM |
JAMES EDWARDS | CONSERVATIVES FOR PROPERTY RIGHTS | 2nd Quarter - Report | $10,875.00 | 2023 | 07/08/2023 @ 03:28 PM |
JORDEN BURT LLP | UNIVERSITY OF TULSA | Year-End Report | $60,000.00 | 2007 | 02/11/2008 @ 10:49 PM |
JORDEN BURT LLP | UNIVERSITY OF TULSA | Mid-Year Report | $60,000.00 | 2007 | 08/14/2007 @ 05:10 PM |
JORDEN BURT LLP | UNIVERSITY OF VIRGINIA | Mid-Year Report | $60,000.00 | 2007 | 08/14/2007 @ 05:16 PM |
JORDEN BURT LLP | UNIVERSITY OF VIRGINIA | Year-End Report | $60,000.00 | 2007 | 02/11/2008 @ 10:57 PM |
LEWIS-BURKE ASSOCIATES, LLC | UNIVERSITY OF VIRGINIA | 4th Quarter - Report | $40,000.00 | 2010 | 01/20/2011 @ 03:35 PM |
LIFE SCIENCES PENNSYLVANIA | LIFE SCIENCES PENNSYLVANIA | 3rd Quarter - Report | 2022 | 10/20/2022 @ 11:32 PM | |
LIFE SCIENCES PENNSYLVANIA | LIFE SCIENCES PENNSYLVANIA | 1st Quarter - Report | 2022 | 04/20/2022 @ 11:15 PM | |
LIFE SCIENCES PENNSYLVANIA | LIFE SCIENCES PENNSYLVANIA | 2nd Quarter - Report | 2022 | 07/19/2022 @ 11:14 AM | |
LIFE SCIENCES PENNSYLVANIA | LIFE SCIENCES PENNSYLVANIA | 4th Quarter - Report | 2022 | 01/19/2023 @ 04:47 PM | |
MEHLMAN CONSULTING, INC. | HEWLETT-PACKARD COMPANY | 4th Quarter - Report | $60,000.00 | 2008 | 01/21/2009 @ 04:12 PM |
MEHLMAN CONSULTING, INC. | HEWLETT-PACKARD COMPANY | 1st Quarter - Report | $60,000.00 | 2009 | 04/20/2009 @ 03:50 PM |
MEHLMAN CONSULTING, INC. | HEWLETT-PACKARD COMPANY | 3rd Quarter - Report | $50,000.00 | 2008 | 10/18/2008 @ 12:26 PM |
MICHIGAN STATE UNIVERSITY | MICHIGAN STATE UNIV | 3rd Quarter - Report | $70,000.00 | 2024 | 10/21/2024 @ 12:08 AM |
MICHIGAN STATE UNIVERSITY | MICHIGAN STATE UNIV | 2nd Quarter - Report | $90,000.00 | 2024 | 07/23/2024 @ 12:20 AM |
MICHIGAN STATE UNIVERSITY | MICHIGAN STATE UNIV | 1st Quarter - Report | $100,000.00 | 2024 | 04/22/2024 @ 11:48 PM |
NATIONAL ASSN OF INDEPENDENT COLLEGES & UNIVERSITIES | NATIONAL ASSN OF INDEPENDENT COLLEGES & UNIVERSITIES | 2nd Quarter - Report | $100,000.00 | 2008 | 07/18/2008 @ 02:25 PM |
NATIONAL ASSN OF INDEPENDENT COLLEGES & UNIVERSITIES | NATIONAL ASSN OF INDEPENDENT COLLEGES & UNIVERSITIES | 1st Quarter - Report | $140,000.00 | 2008 | 04/21/2008 @ 01:46 PM |
NATIONAL ASSN OF INDEPENDENT COLLEGES & UNIVERSITIES | NATIONAL ASSN OF INDEPENDENT COLLEGES & UNIVERSITIES | Mid-Year Report | $250,000.00 | 2007 | 08/14/2007 @ 09:02 AM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 2nd Quarter - Report | $170,000.00 | 2023 | 07/20/2023 @ 11:21 AM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 4th Quarter - Report | $190,000.00 | 2022 | 01/19/2023 @ 01:50 PM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 4th Quarter - Report | $160,000.00 | 2023 | 01/19/2024 @ 01:36 PM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 3rd Quarter - Report | $200,000.00 | 2024 | 10/18/2024 @ 02:26 PM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 3rd Quarter - Report | $210,000.00 | 2022 | 10/18/2022 @ 02:35 PM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 1st Quarter - Report | $180,000.00 | 2023 | 04/20/2023 @ 02:46 PM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 2nd Quarter - Report | $210,000.00 | 2024 | 07/22/2024 @ 01:47 PM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 1st Quarter - Report | $200,000.00 | 2024 | 04/22/2024 @ 10:19 AM |
NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 3rd Quarter - Report | $140,000.00 | 2023 | 10/17/2023 @ 10:35 AM |
NATIONAL TAXPAYERS UNION | NATIONAL TAXPAYERS UNION | 1st Quarter - Report | $30,000.00 | 2022 | 04/20/2022 @ 10:55 AM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 1st Quarter - Report | $100,000.00 | 2024 | 04/22/2024 @ 12:03 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 1st Quarter - Report | $30,000.00 | 2022 | 04/20/2022 @ 08:43 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 2nd Quarter - Report | $30,000.00 | 2023 | 07/20/2023 @ 10:52 AM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 4th Quarter - Report | $30,000.00 | 2021 | 01/20/2022 @ 04:45 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 2nd Quarter - Report | $40,000.00 | 2022 | 07/20/2022 @ 09:51 AM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 1st Quarter - Report | $50,000.00 | 2023 | 04/20/2023 @ 09:00 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 3rd Quarter - Report | $60,000.00 | 2022 | 10/20/2022 @ 12:29 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 3rd Quarter - Report | $30,000.00 | 2021 | 10/20/2021 @ 01:58 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 1st Quarter - Report | $30,000.00 | 2021 | 04/20/2021 @ 09:19 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 3rd Quarter - Report | $30,000.00 | 2023 | 10/20/2023 @ 12:13 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 4th Quarter - Report | $40,000.00 | 2022 | 01/20/2023 @ 07:42 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 2nd Quarter - Report | $30,000.00 | 2021 | 07/20/2021 @ 01:07 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 3rd Quarter - Report | $50,000.00 | 2024 | 10/21/2024 @ 01:15 PM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 2nd Quarter - Report | $40,000.00 | 2024 | 07/22/2024 @ 10:50 AM |
NORTH CAROLINA STATE UNIVERSITY | NORTH CAROLINA STATE UNIVERSITY | 4th Quarter - Report | $30,000.00 | 2023 | 01/22/2024 @ 09:50 AM |
NORTHWESTERN UNIV | NORTHWESTERN UNIV | 1st Quarter - Report | $110,000.00 | 2024 | 04/22/2024 @ 11:32 AM |
NOVARTIS | NOVARTIS | 4th Quarter - Report | $860,000.00 | 2023 | 01/22/2024 @ 09:37 AM |
NOVARTIS | NOVARTIS | 4th Quarter - Amendment | $1,760,000.00 | 2022 | 10/20/2023 @ 04:46 PM |
NOVARTIS | NOVARTIS | 1st Quarter - Report | $3,510,000.00 | 2024 | 04/19/2024 @ 05:06 PM |
NOVARTIS | NOVARTIS | 3rd Quarter - Report | $1,360,000.00 | 2023 | 10/20/2023 @ 01:39 PM |
NOVARTIS | NOVARTIS | 3rd Quarter - Report | $740,000.00 | 2024 | 10/21/2024 @ 04:55 PM |
NOVARTIS | NOVARTIS | 3rd Quarter - Report | $1,190,000.00 | 2020 | 10/20/2020 @ 09:59 AM |
NOVARTIS | NOVARTIS | 2nd Quarter - Report | $780,000.00 | 2020 | 07/20/2020 @ 04:50 PM |
NOVARTIS | NOVARTIS | 1st Quarter - Report | $2,170,000.00 | 2021 | 04/20/2021 @ 04:44 PM |
NOVARTIS | NOVARTIS | 1st Quarter - Report | $1,300,000.00 | 2022 | 04/20/2022 @ 04:34 PM |
NOVARTIS | NOVARTIS | 2nd Quarter - Report | $1,010,000.00 | 2019 | 07/22/2019 @ 09:43 AM |
NOVARTIS | NOVARTIS | 3rd Quarter - Report | $1,140,000.00 | 2019 | 10/21/2019 @ 10:08 AM |
NOVARTIS | NOVARTIS | 4th Quarter - Report | $620,000.00 | 2019 | 01/21/2020 @ 03:25 PM |
NOVARTIS | NOVARTIS | 1st Quarter - Report | $3,350,000.00 | 2020 | 04/20/2020 @ 05:50 PM |
NOVARTIS | NOVARTIS | 4th Quarter - Report | $660,000.00 | 2020 | 01/20/2021 @ 06:25 PM |
NOVARTIS | NOVARTIS | 2nd Quarter - Report | $1,680,000.00 | 2021 | 07/20/2021 @ 04:42 PM |
NOVARTIS | NOVARTIS | 3rd Quarter - Report | $1,270,000.00 | 2021 | 10/20/2021 @ 10:11 AM |
NOVARTIS | NOVARTIS | 4th Quarter - Report | $1,460,000.00 | 2021 | 01/20/2022 @ 12:48 PM |
NOVARTIS | NOVARTIS | 2nd Quarter - Report | $1,010,000.00 | 2024 | 07/22/2024 @ 09:31 AM |
NOVARTIS | NOVARTIS | 4th Quarter - Amendment | $960,000.00 | 2023 | 10/21/2024 @ 05:08 PM |
NOVARTIS | NOVARTIS | 3rd Quarter - Report | $850,000.00 | 2022 | 10/20/2022 @ 12:37 PM |
NOVARTIS | NOVARTIS | 2nd Quarter - Report | $930,000.00 | 2023 | 07/20/2023 @ 01:03 PM |
NOVARTIS | NOVARTIS | 4th Quarter - Report | $880,000.00 | 2022 | 01/20/2023 @ 02:08 PM |
NOVARTIS | NOVARTIS | 1st Quarter - Report | $2,440,000.00 | 2023 | 04/20/2023 @ 12:49 PM |
NOVARTIS | NOVARTIS | 2nd Quarter - Report | $1,790,000.00 | 2022 | 07/20/2022 @ 03:57 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2019 | 07/22/2019 @ 12:37 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2021 | 07/19/2021 @ 04:05 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Termination | $60,000.00 | 2023 | 04/20/2023 @ 01:50 AM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2020 | 01/19/2021 @ 06:48 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2020 | 10/19/2020 @ 04:15 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2022 | 07/20/2022 @ 05:10 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Amendment | $60,000.00 | 2020 | 01/21/2021 @ 06:25 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2021 | 01/19/2022 @ 01:34 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2022 | 01/18/2023 @ 08:13 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2020 | 07/20/2020 @ 03:42 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2019 | 01/10/2020 @ 03:10 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2022 | 04/20/2022 @ 02:36 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2019 | 10/21/2019 @ 05:40 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2021 | 10/19/2021 @ 12:46 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2021 | 04/20/2021 @ 06:32 PM |
NVG, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2020 | 04/20/2020 @ 04:17 PM |
NVG, LLC | PFIZER INC. | 4th Quarter - Report | $80,000.00 | 2020 | 01/21/2021 @ 08:32 AM |
NVG, LLC | SANOFI US | 4th Quarter - Report | $10,000.00 | 2017 | 01/22/2018 @ 06:07 PM |
OREGON HEALTH & SCIENCE UNIVERSITY | OREGON HEALTH & SCIENCE UNIVERSITY | 2nd Quarter - Report | $70,000.00 | 2010 | 10/20/2010 @ 02:27 PM |
OREGON HEALTH & SCIENCE UNIVERSITY | OREGON HEALTH & SCIENCE UNIVERSITY | 3rd Quarter - Report | $70,000.00 | 2010 | 10/20/2010 @ 02:33 PM |
OREGON HEALTH & SCIENCE UNIVERSITY | OREGON HEALTH & SCIENCE UNIVERSITY | Mid-Year Report | $100,000.00 | 2007 | 08/13/2007 @ 05:40 PM |
OREGON HEALTH & SCIENCE UNIVERSITY | OREGON HEALTH & SCIENCE UNIVERSITY | 4th Quarter - Report | $90,000.00 | 2010 | 01/20/2011 @ 04:31 PM |
OREGON HEALTH & SCIENCE UNIVERSITY | OREGON HEALTH & SCIENCE UNIVERSITY | 2nd Quarter - Report | $90,000.00 | 2010 | 07/19/2010 @ 04:49 PM |
OREGON HEALTH & SCIENCE UNIVERSITY | OREGON HEALTH & SCIENCE UNIVERSITY | Year-End Report | $30,000.00 | 2007 | 02/13/2008 @ 05:15 PM |
OREGON STATE UNIVERSITY | OREGON STATE UNIVERSITY | 1st Quarter - Report | $40,000.00 | 2018 | 04/09/2018 @ 08:48 PM |
OREGON STATE UNIVERSITY | OREGON STATE UNIVERSITY | 1st Quarter - Report | $40,000.00 | 2017 | 03/28/2017 @ 05:19 PM |
OREGON STATE UNIVERSITY | OREGON STATE UNIVERSITY | 2nd Quarter - Report | $40,000.00 | 2017 | 07/19/2017 @ 08:46 PM |
OREGON STATE UNIVERSITY | OREGON STATE UNIVERSITY | 4th Quarter - Report | $40,000.00 | 2017 | 01/18/2018 @ 05:27 PM |
OREGON STATE UNIVERSITY | OREGON STATE UNIVERSITY | 3rd Quarter - Report | $40,000.00 | 2017 | 10/13/2017 @ 03:28 PM |
OREGON STATE UNIVERSITY | OREGON STATE UNIVERSITY | 1st Quarter - Amendment | $40,000.00 | 2017 | 04/06/2017 @ 08:01 PM |
PFIZER INC. | PFIZER INC. | 3rd Quarter - Report | $3,250,000.00 | 2022 | 10/20/2022 @ 06:55 PM |
PFIZER INC. | PFIZER INC. | 4th Quarter - Report | $3,050,000.00 | 2022 | 01/20/2023 @ 06:00 PM |
PFIZER INC. | PFIZER INC. | 2nd Quarter - Report | $3,440,000.00 | 2022 | 07/20/2022 @ 09:37 PM |
PFIZER INC. | PFIZER INC. | 3rd Quarter - Report | $4,050,000.00 | 2023 | 10/20/2023 @ 06:27 PM |
PFIZER INC. | PFIZER INC. | 1st Quarter - Report | $4,600,000.00 | 2023 | 04/20/2023 @ 10:35 PM |
PFIZER INC. | PFIZER INC. | 2nd Quarter - Amendment | $3,480,000.00 | 2022 | 09/02/2022 @ 07:13 PM |
PFIZER INC. | PFIZER INC. | 4th Quarter - Report | $3,000,000.00 | 2023 | 01/19/2024 @ 06:00 PM |
PFIZER INC. | PFIZER INC. | 1st Quarter - Amendment | $3,820,000.00 | 2022 | 09/02/2022 @ 07:11 PM |
PFIZER INC. | PFIZER INC. | 1st Quarter - Amendment | $2,730,000.00 | 2022 | 05/16/2023 @ 07:08 PM |
PFIZER INC. | PFIZER INC. | 2nd Quarter - Amendment | $2,390,000.00 | 2022 | 05/16/2023 @ 07:10 PM |
PFIZER INC. | PFIZER INC. | 2nd Quarter - Report | $2,480,000.00 | 2023 | 07/20/2023 @ 05:30 PM |
PFIZER INC. | PFIZER INC. | 1st Quarter - Report | $2,740,000.00 | 2022 | 04/20/2022 @ 05:40 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $5,960,000.00 | 2020 | 10/20/2020 @ 02:04 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $5,410,000.00 | 2020 | 07/20/2020 @ 04:40 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $9,020,000.00 | 2020 | 04/20/2020 @ 03:50 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $6,450,000.00 | 2019 | 01/21/2020 @ 05:05 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $6,230,000.00 | 2019 | 10/21/2019 @ 03:38 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Amendment | $6,310,000.00 | 2019 | 08/08/2019 @ 12:47 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $6,220,000.00 | 2019 | 07/22/2019 @ 10:12 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $9,910,000.00 | 2019 | 04/22/2019 @ 12:04 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $6,030,000.00 | 2018 | 01/22/2019 @ 04:14 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $5,990,000.00 | 2018 | 10/22/2018 @ 02:55 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $5,540,000.00 | 2018 | 07/20/2018 @ 12:30 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $5,570,000.00 | 2017 | 10/20/2017 @ 01:46 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $6,000,000.00 | 2017 | 07/20/2017 @ 01:28 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $7,980,000.00 | 2017 | 04/20/2017 @ 05:14 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $4,990,000.00 | 2016 | 01/23/2017 @ 06:45 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $4,130,000.00 | 2016 | 10/20/2016 @ 11:17 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $5,820,000.00 | 2016 | 07/20/2016 @ 11:01 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $5,950,000.00 | 2016 | 04/20/2016 @ 06:02 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $7,990,000.00 | 2023 | 04/20/2023 @ 09:46 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $6,300,000.00 | 2023 | 07/20/2023 @ 05:00 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $6,880,000.00 | 2024 | 10/21/2024 @ 12:10 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $9,960,000.00 | 2018 | 04/20/2018 @ 11:05 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $9,600,000.00 | 2024 | 04/22/2024 @ 05:08 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $5,880,000.00 | 2017 | 01/22/2018 @ 04:49 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $6,340,000.00 | 2022 | 07/20/2022 @ 03:05 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $6,960,000.00 | 2024 | 07/22/2024 @ 02:40 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Amendment | $4,550,000.00 | 2016 | 10/20/2016 @ 02:18 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $7,270,000.00 | 2022 | 10/20/2022 @ 02:15 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $7,160,000.00 | 2021 | 01/20/2022 @ 02:10 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $6,430,000.00 | 2023 | 01/22/2024 @ 01:35 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $8,070,000.00 | 2022 | 04/20/2022 @ 09:59 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $6,610,000.00 | 2022 | 01/20/2023 @ 02:35 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $6,370,000.00 | 2023 | 10/20/2023 @ 02:26 PM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1st Quarter - Report | $8,540,000.00 | 2021 | 04/20/2021 @ 09:06 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3rd Quarter - Report | $7,440,000.00 | 2021 | 10/20/2021 @ 10:44 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2nd Quarter - Report | $6,430,000.00 | 2021 | 07/20/2021 @ 11:16 AM |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4th Quarter - Report | $5,130,000.00 | 2020 | 01/21/2021 @ 01:35 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2017 | 10/20/2017 @ 09:46 AM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2022 | 01/19/2023 @ 02:18 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2017 | 01/19/2018 @ 02:13 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Amendment | $50,000.00 | 2018 | 05/03/2018 @ 03:13 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2018 | 07/19/2018 @ 04:17 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2017 | 04/18/2017 @ 01:30 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2018 | 10/12/2018 @ 02:39 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2017 | 07/18/2017 @ 04:28 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2019 | 04/18/2019 @ 01:54 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2019 | 07/22/2019 @ 11:31 AM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2018 | 04/19/2018 @ 02:41 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Termination | $50,000.00 | 2023 | 04/19/2023 @ 01:12 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2019 | 10/21/2019 @ 02:40 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2020 | 04/16/2020 @ 10:15 AM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2020 | 10/15/2020 @ 10:04 AM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2019 | 01/13/2020 @ 02:52 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2020 | 07/17/2020 @ 04:13 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2022 | 04/14/2022 @ 04:00 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2022 | 10/18/2022 @ 09:29 AM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2022 | 07/13/2022 @ 02:43 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2016 | 04/18/2016 @ 02:34 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2016 | 07/15/2016 @ 01:27 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2018 | 01/17/2019 @ 01:14 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2016 | 10/17/2016 @ 12:36 PM |
PORTERFIELD, FETTIG & SEARS, LLC | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2016 | 01/18/2017 @ 10:55 AM |
P STREET PROJECT, INC. | P STREET PROJECT, INC. | 1st Quarter - Report | $20,000.00 | 2024 | 04/22/2024 @ 05:01 PM |
P STREET PROJECT, INC. | P STREET PROJECT, INC. | 2nd Quarter - Report | $20,000.00 | 2024 | 07/22/2024 @ 06:56 PM |
P STREET PROJECT, INC. | P STREET PROJECT, INC. | 3rd Quarter - Report | $20,000.00 | 2023 | 10/19/2023 @ 05:06 PM |
P STREET PROJECT, INC. | P STREET PROJECT, INC. | 4th Quarter - Report | 2023 | 01/22/2024 @ 01:31 PM | |
PUBLIC CITIZEN | PUBLIC CITIZEN | 1st Quarter - Report | $90,000.00 | 2023 | 04/20/2023 @ 08:45 AM |
PUBLIC CITIZEN | PUBLIC CITIZEN | 2nd Quarter - Report | $73,300.00 | 2024 | 07/12/2024 @ 02:06 PM |
PUBLIC CITIZEN | PUBLIC CITIZEN | 3rd Quarter - Amendment | $75,000.00 | 2023 | 10/19/2023 @ 01:25 PM |
PUBLIC CITIZEN | PUBLIC CITIZEN | 4th Quarter - Report | $69,000.00 | 2023 | 01/18/2024 @ 11:12 AM |
PUBLIC CITIZEN | PUBLIC CITIZEN | 1st Quarter - Report | $88,000.00 | 2024 | 04/02/2024 @ 10:46 AM |
PUBLIC CITIZEN | PUBLIC CITIZEN | 2nd Quarter - Report | $72,000.00 | 2023 | 07/20/2023 @ 02:53 PM |
PUBLIC CITIZEN | PUBLIC CITIZEN | 2nd Quarter - Amendment | $72,000.00 | 2023 | 10/19/2023 @ 01:19 PM |
PUBLIC CITIZEN | PUBLIC CITIZEN | 3rd Quarter - Report | $75,000.00 | 2023 | 10/11/2023 @ 02:31 PM |
REGENXBIO | REGENXBIO | 3rd Quarter - Report | $94,000.00 | 2023 | 10/16/2023 @ 11:06 PM |
REGENXBIO | REGENXBIO | 1st Quarter - Report | $60,000.00 | 2021 | 04/21/2021 @ 02:24 PM |
REGENXBIO | REGENXBIO | 4th Quarter - Termination | $91,000.00 | 2023 | 01/22/2024 @ 02:04 PM |
REGENXBIO | REGENXBIO | 1st Quarter - Report | $163,000.00 | 2023 | 04/19/2023 @ 04:35 PM |
REGENXBIO | REGENXBIO | 4th Quarter - Report | $60,000.00 | 2021 | 01/17/2022 @ 11:07 PM |
REGENXBIO | REGENXBIO | 2nd Quarter - Report | $90,000.00 | 2023 | 07/19/2023 @ 03:41 PM |
REGENXBIO | REGENXBIO | 3rd Quarter - Amendment | $75,000.00 | 2021 | 12/14/2021 @ 12:31 AM |
REGENXBIO | REGENXBIO | 3rd Quarter - Report | $40,000.00 | 2021 | 10/29/2021 @ 09:18 AM |
REGENXBIO | REGENXBIO | 3rd Quarter - Report | $70,000.00 | 2022 | 10/15/2022 @ 09:41 PM |
REGENXBIO | REGENXBIO | 2nd Quarter - Report | $82,000.00 | 2022 | 07/20/2022 @ 02:04 PM |
REGENXBIO | REGENXBIO | 1st Quarter - Report | $150,000.00 | 2022 | 04/20/2022 @ 09:35 PM |
REGENXBIO | REGENXBIO | 2nd Quarter - Report | $40,000.00 | 2021 | 07/20/2021 @ 04:43 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2019 | 01/21/2020 @ 11:00 AM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2022 | 10/20/2022 @ 01:28 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2018 | 10/22/2018 @ 04:57 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Amendment | $50,000.00 | 2019 | 01/22/2020 @ 01:36 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2021 | 10/19/2021 @ 01:11 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $30,000.00 | 2016 | 04/20/2016 @ 06:19 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2017 | 10/20/2017 @ 02:27 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Amendment | $50,000.00 | 2020 | 01/20/2021 @ 01:23 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2020 | 07/20/2020 @ 05:56 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2022 | 07/19/2022 @ 04:37 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2021 | 01/20/2022 @ 09:46 AM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2021 | 07/20/2021 @ 12:59 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2021 | 04/19/2021 @ 04:00 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2020 | 10/19/2020 @ 01:14 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Amendment | $50,000.00 | 2019 | 01/22/2020 @ 01:37 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2019 | 10/21/2019 @ 05:44 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2019 | 04/22/2019 @ 10:01 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2018 | 01/22/2019 @ 03:52 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2018 | 07/20/2018 @ 03:52 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2017 | 01/22/2018 @ 10:30 AM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2018 | 04/20/2018 @ 04:12 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2017 | 07/20/2017 @ 01:35 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2017 | 04/20/2017 @ 04:41 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $50,000.00 | 2016 | 01/23/2017 @ 02:41 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $50,000.00 | 2016 | 10/20/2016 @ 03:02 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2016 | 07/20/2016 @ 04:22 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2022 | 01/18/2023 @ 11:15 AM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $50,000.00 | 2019 | 07/22/2019 @ 02:02 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2023 | 07/18/2023 @ 09:25 AM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2023 | 04/20/2023 @ 11:01 AM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2023 | 10/18/2023 @ 04:35 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2023 | 01/21/2024 @ 09:25 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2024 | 04/21/2024 @ 06:32 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2022 | 04/17/2022 @ 04:00 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $50,000.00 | 2020 | 04/20/2020 @ 12:49 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) | 2nd Quarter - Report | $80,000.00 | 2024 | 07/18/2024 @ 03:33 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) | 3rd Quarter - Report | $80,000.00 | 2024 | 10/20/2024 @ 02:10 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) | 4th Quarter - Report | $80,000.00 | 2023 | 01/21/2024 @ 09:34 PM |
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) | BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) | 1st Quarter - Report | $80,000.00 | 2024 | 04/21/2024 @ 06:38 PM |
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | 2nd Quarter - Report | $55,000.00 | 2022 | 07/20/2022 @ 03:15 PM |
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | 1st Quarter - Report | $30,000.00 | 2021 | 05/05/2021 @ 09:49 AM |
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | 3rd Quarter - Report | $45,000.00 | 2022 | 10/24/2022 @ 03:36 PM |
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | 3rd Quarter - Report | $20,000.00 | 2024 | 10/21/2024 @ 07:04 PM |
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | 1st Quarter - Report | $45,000.00 | 2022 | 04/20/2022 @ 12:29 PM |
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) | 4th Quarter - Report | $35,000.00 | 2022 | 01/20/2023 @ 01:07 PM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 3rd Quarter - Report | $1,490,000.00 | 2021 | 10/20/2021 @ 03:48 PM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 2nd Quarter - Amendment | $1,790,000.00 | 2021 | 11/03/2021 @ 10:09 AM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 2nd Quarter - Report | $1,890,000.00 | 2021 | 07/20/2021 @ 03:52 PM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 2nd Quarter - Report | $1,250,000.00 | 2023 | 07/20/2023 @ 05:48 PM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 1st Quarter - Report | $1,460,000.00 | 2023 | 04/20/2023 @ 11:10 AM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 2nd Quarter - Report | $570,000.00 | 2019 | 07/22/2019 @ 06:14 PM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 1st Quarter - Report | $650,000.00 | 2021 | 04/19/2021 @ 05:42 PM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 1st Quarter - Amendment | $690,000.00 | 2021 | 11/03/2021 @ 10:07 AM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 4th Quarter - Report | $780,000.00 | 2022 | 01/19/2023 @ 06:16 PM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 2nd Quarter - Report | $1,050,000.00 | 2024 | 07/22/2024 @ 03:20 PM |
TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | 1st Quarter - Report | $1,300,000.00 | 2022 | 04/20/2022 @ 01:17 PM |
TECHNOLOGY COUNCILS OF NORTH AMERICA | TECHNOLOGY COUNCILS OF NORTH AMERICA | 2nd Quarter - Report | 2024 | 07/20/2024 @ 01:01 PM | |
TECHNOLOGY COUNCILS OF NORTH AMERICA | TECHNOLOGY COUNCILS OF NORTH AMERICA | 1st Quarter - Report | 2024 | 04/24/2024 @ 07:38 AM | |
TECHNOLOGY COUNCILS OF NORTH AMERICA | TECHNOLOGY COUNCILS OF NORTH AMERICA | 3rd Quarter - Report | 2024 | 10/15/2024 @ 10:07 AM | |
THE PENNSYLVANIA STATE UNIVERSITY | PENNSYLVANIA STATE UNIVERSITY | 1st Quarter - Report | $160,000.00 | 2024 | 04/22/2024 @ 09:18 PM |
THE UNIVERSITY OF CHICAGO | THE UNIVERSITY OF CHICAGO | Year-End Report | $80,000.00 | 2007 | 02/20/2008 @ 03:14 PM |
THE UNIVERSITY OF CHICAGO | THE UNIVERSITY OF CHICAGO | Year-End Report | $80,000.00 | 2007 | 02/20/2008 @ 03:14 PM |
THE UNIVERSITY OF CHICAGO | THE UNIVERSITY OF CHICAGO | Year-End Report | $80,000.00 | 2007 | 02/20/2008 @ 03:14 PM |
THE UNIVERSITY OF NORTH CAROLINA SYSTEM | THE UNIVERSITY OF NORTH CAROLINA SYSTEM | 1st Quarter - Report | $120,000.00 | 2009 | 04/19/2009 @ 12:50 AM |
THE UNIVERSITY OF TEXAS AT AUSTIN | THE UNIVERSITY OF TEXAS AT AUSTIN | 1st Quarter - Report | $130,000.00 | 2024 | 04/25/2024 @ 02:17 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 3rd Quarter - Amendment | $60,000.00 | 2016 | 11/13/2017 @ 12:49 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2017 | 10/20/2017 @ 09:14 AM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2018 | 01/18/2019 @ 02:47 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2018 | 10/22/2018 @ 03:43 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2018 | 07/20/2018 @ 12:53 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2018 | 04/20/2018 @ 12:22 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2017 | 01/22/2018 @ 12:00 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2017 | 07/20/2017 @ 09:14 AM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 3rd Quarter - Amendment | $60,000.00 | 2016 | 01/24/2017 @ 05:07 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 4th Quarter - Report | $60,000.00 | 2016 | 01/23/2017 @ 09:42 AM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 3rd Quarter - Report | $60,000.00 | 2016 | 10/20/2016 @ 09:47 AM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 1st Quarter - Termination | $60,000.00 | 2019 | 04/22/2019 @ 04:02 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2023 | 07/12/2023 @ 04:23 PM | |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 2nd Quarter - Report | $60,000.00 | 2016 | 07/20/2016 @ 10:04 AM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2016 | 04/20/2016 @ 04:18 PM |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2023 | 07/12/2023 @ 04:23 PM | |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | Registration - Amendment | 2023 | 07/12/2023 @ 04:23 PM | |
TIBER CREEK GROUP | ASTELLAS PHARMA US, INC. | 1st Quarter - Report | $60,000.00 | 2017 | 04/20/2017 @ 09:39 AM |
TIBER CREEK GROUP | PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | 1st Quarter - Report | $50,000.00 | 2024 | 04/12/2024 @ 04:10 PM |
TIBER CREEK GROUP | PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | 2nd Quarter - Report | $50,000.00 | 2024 | 07/15/2024 @ 02:19 PM |
TIBER CREEK GROUP | PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | 3rd Quarter - Report | $50,000.00 | 2024 | 10/16/2024 @ 08:37 PM |
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2nd Quarter - Report | $150,000.00 | 2024 | 07/22/2024 @ 01:33 PM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | 4th Quarter - Report | $120,000.00 | 2010 | 01/20/2011 @ 05:12 PM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | Mid-Year Report | $360,000.00 | 2006 | 08/09/2006 @ 12:00 AM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | 1st Quarter - Amendment | $270,000.00 | 2008 | 04/22/2008 @ 11:51 AM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | 3rd Quarter - Report | $430,000.00 | 2023 | 10/19/2023 @ 05:13 PM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | 3rd Quarter - Report | $450,000.00 | 2024 | 10/18/2024 @ 09:41 AM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | 4th Quarter - Report | $170,000.00 | 2011 | 01/20/2012 @ 03:27 PM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | 2nd Quarter - Report | $170,000.00 | 2021 | 07/20/2021 @ 10:35 AM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | 1st Quarter - Report | $730,000.00 | 2024 | 04/22/2024 @ 04:02 PM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | 1st Quarter - Report | $260,000.00 | 2008 | 04/21/2008 @ 05:53 PM |
UNIVERSITY OF CALIFORNIA | UNIVERSITY OF CALIFORNIA | Year-End Report | $320,000.00 | 2006 | 02/13/2007 @ 11:26 AM |
UNIVERSITY OF ILLINOIS | UNIVERSITY OF ILLINOIS | 1st Quarter - Report | $170,000.00 | 2024 | 04/22/2024 @ 04:03 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | Year-End Report | $160,000.00 | 2007 | 02/14/2008 @ 01:45 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Report | $86,662.00 | 2016 | 10/19/2016 @ 11:40 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $86,662.00 | 2016 | 01/25/2017 @ 05:36 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $86,662.00 | 2016 | 04/19/2016 @ 01:47 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $86,662.00 | 2015 | 01/06/2016 @ 05:19 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Amendment | $86,662.00 | 2015 | 10/09/2015 @ 10:35 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $86,662.00 | 2016 | 07/18/2016 @ 12:19 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Report | $85,562.86 | 2014 | 10/14/2014 @ 04:19 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $85,562.86 | 2014 | 07/07/2014 @ 02:28 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $85,562.86 | 2013 | 01/07/2014 @ 05:28 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Report | $85,562.86 | 2013 | 10/16/2013 @ 10:02 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $28,999.36 | 2012 | 01/07/2013 @ 09:54 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $88,684.00 | 2011 | 01/18/2012 @ 05:12 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Report | $88,684.00 | 2011 | 10/19/2011 @ 02:29 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $110,000.00 | 2010 | 07/16/2010 @ 05:28 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $110,000.00 | 2010 | 04/07/2010 @ 10:00 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $110,000.00 | 2009 | 01/20/2010 @ 11:53 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Report | $110,000.00 | 2009 | 10/19/2009 @ 04:24 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $110,000.00 | 2009 | 07/17/2009 @ 04:09 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $110,000.00 | 2008 | 01/20/2009 @ 12:54 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Report | $110,000.00 | 2008 | 10/20/2008 @ 04:25 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $110,000.00 | 2008 | 04/21/2008 @ 03:05 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | Mid-Year Report | $160,000.00 | 2007 | 02/14/2008 @ 11:32 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | Mid-Year Report | 2007 | 02/14/2008 @ 09:20 AM | |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | Mid-Year Report | $80,000.00 | 2007 | 08/14/2007 @ 02:54 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $86,662.00 | 2015 | 04/14/2015 @ 05:12 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $86,662.00 | 2015 | 07/10/2015 @ 01:15 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $85,562.86 | 2014 | 04/10/2014 @ 10:24 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $29,312.86 | 2013 | 07/08/2013 @ 12:52 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Report | $88,684.00 | 2012 | 10/08/2012 @ 10:26 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $88,684.00 | 2012 | 04/02/2012 @ 10:31 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $88,684.00 | 2011 | 07/08/2011 @ 04:38 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $88,684.00 | 2011 | 04/19/2011 @ 12:35 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 3rd Quarter - Report | $110,000.00 | 2010 | 10/11/2010 @ 04:35 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $29,312.86 | 2013 | 04/08/2013 @ 11:14 AM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | Year-End Report | $80,000.00 | 2006 | 02/13/2007 @ 04:57 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $110,000.00 | 2008 | 07/21/2008 @ 12:47 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $85,562.86 | 2014 | 01/13/2015 @ 12:21 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 2nd Quarter - Report | $88,684.00 | 2012 | 07/03/2012 @ 04:59 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 1st Quarter - Report | $110,000.00 | 2009 | 04/17/2009 @ 01:03 PM |
UNIVERSITY OF IOWA | UNIVERSITY OF IOWA | 4th Quarter - Report | $88,684.00 | 2010 | 01/12/2011 @ 02:34 PM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 1st Quarter - Report | $70,000.00 | 2022 | 04/20/2022 @ 12:14 PM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 4th Quarter - Report | $60,000.00 | 2022 | 01/20/2023 @ 02:05 PM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 3rd Quarter - Report | $100,000.00 | 2010 | 10/19/2010 @ 09:43 AM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 1st Quarter - Report | $70,000.00 | 2022 | 04/20/2022 @ 12:14 PM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 2nd Quarter - Report | $80,000.00 | 2022 | 07/20/2022 @ 10:12 AM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 4th Quarter - Report | $120,000.00 | 2010 | 01/20/2011 @ 08:41 AM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 4th Quarter - Report | $70,000.00 | 2020 | 01/18/2021 @ 01:01 PM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 3rd Quarter - Report | $80,000.00 | 2022 | 10/20/2022 @ 01:34 PM |
UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN | 1st Quarter - Report | $110,000.00 | 2023 | 04/20/2023 @ 03:40 PM |
UNIVERSITY OF PITTSBURGH | UNIVERSITY OF PITTSBURGH | Mid-Year Report | $180,000.00 | 2007 | 08/03/2007 @ 08:16 PM |
UNIVERSITY OF PITTSBURGH | UNIVERSITY OF PITTSBURGH | 4th Quarter - Report | $80,000.00 | 2012 | 01/18/2013 @ 01:49 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 3rd Quarter - Report | $100,000.00 | 2017 | 10/20/2017 @ 12:14 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 2nd Quarter - Report | $90,000.00 | 2017 | 07/21/2017 @ 04:30 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 2nd Quarter - Report | $80,000.00 | 2020 | 07/20/2020 @ 06:25 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 3rd Quarter - Report | $90,000.00 | 2020 | 10/20/2020 @ 05:32 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 2nd Quarter - Report | $80,000.00 | 2019 | 07/22/2019 @ 02:24 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 1st Quarter - Report | $90,000.00 | 2019 | 04/22/2019 @ 05:07 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 4th Quarter - Report | $70,000.00 | 2018 | 01/22/2019 @ 04:49 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 1st Quarter - Report | $80,000.00 | 2018 | 04/20/2018 @ 04:15 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 4th Quarter - Report | $90,000.00 | 2017 | 01/22/2018 @ 02:21 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 1st Quarter - Report | $150,000.00 | 2017 | 04/20/2017 @ 03:52 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 4th Quarter - Report | $80,000.00 | 2020 | 01/16/2021 @ 07:32 AM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 3rd Quarter - Report | $90,000.00 | 2018 | 10/17/2018 @ 05:05 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 2nd Quarter - Report | $90,000.00 | 2018 | 07/18/2018 @ 02:56 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 4th Quarter - Report | $60,000.00 | 2019 | 01/21/2020 @ 12:28 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 1st Quarter - Report | $100,000.00 | 2020 | 04/20/2020 @ 02:44 PM |
UNIVERSITY OF ROCHESTER | UNIVERSITY OF ROCHESTER | 3rd Quarter - Report | $80,000.00 | 2019 | 10/21/2019 @ 12:35 PM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 4th Quarter - Report | $70,000.00 | 2016 | 01/23/2017 @ 01:15 PM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 3rd Quarter - Report | $80,000.00 | 2017 | 10/20/2017 @ 12:51 PM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 1st Quarter - Report | $90,000.00 | 2017 | 04/24/2017 @ 11:45 AM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 3rd Quarter - Report | $70,000.00 | 2018 | 10/19/2018 @ 11:37 AM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 4th Quarter - Report | $80,000.00 | 2017 | 01/20/2018 @ 08:35 AM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 1st Quarter - Report | $90,000.00 | 2018 | 04/20/2018 @ 05:26 PM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 4th Quarter - Report | $70,000.00 | 2018 | 01/22/2019 @ 03:07 PM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 2nd Quarter - Report | $70,000.00 | 2018 | 07/16/2018 @ 03:41 PM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 2nd Quarter - Report | $80,000.00 | 2017 | 07/20/2017 @ 11:02 AM |
UNIVERSITY OF WISCONSIN-MADISON | UNIVERSITY OF WISCONSIN-MADISON | 3rd Quarter - Report | $90,000.00 | 2014 | 10/17/2014 @ 04:56 PM |
VANDERBILT UNIVERSITY | VANDERBILT UNIVERSITY | 3rd Quarter - Report | $90,000.00 | 2013 | 12/30/2013 @ 06:34 PM |
VANDERBILT UNIVERSITY | VANDERBILT UNIVERSITY | 1st Quarter - Report | $40,000.00 | 2020 | 04/20/2020 @ 02:22 PM |
VANDERBILT UNIVERSITY | VANDERBILT UNIVERSITY | 2nd Quarter - Report | $100,000.00 | 2023 | 07/19/2023 @ 05:39 PM |
VANDERBILT UNIVERSITY | VANDERBILT UNIVERSITY | 4th Quarter - Report | $15,000.00 | 2018 | 01/22/2019 @ 12:54 PM |
VANDERBILT UNIVERSITY | VANDERBILT UNIVERSITY | 1st Quarter - Report | $60,000.00 | 2023 | 04/20/2023 @ 01:28 PM |
VANDERBILT UNIVERSITY | VANDERBILT UNIVERSITY | 1st Quarter - Report | $60,000.00 | 2023 | 04/20/2023 @ 01:28 PM |
VANDERBILT UNIVERSITY | VANDERBILT UNIVERSITY | 3rd Quarter - Report | $50,000.00 | 2013 | 10/21/2013 @ 05:58 PM |
VANDERBILT UNIVERSITY | VANDERBILT UNIVERSITY | 3rd Quarter - Amendment | $90,000.00 | 2013 | 12/30/2013 @ 06:38 PM |
VANDERBILT UNIVERSITY MEDICAL CENTER | VANDERBILT UNIVERSITY MEDICAL CENTER | 4th Quarter - Report | $30,000.00 | 2023 | 01/22/2024 @ 04:11 PM |
WARING FEDERAL STRATEGIES | AUTM | 2nd Quarter - Report | $10,000.00 | 2024 | 07/18/2024 @ 01:04 PM |
WARING FEDERAL STRATEGIES | AUTM | 3rd Quarter - Report | $9,000.00 | 2022 | 10/18/2022 @ 10:30 AM |
WARING FEDERAL STRATEGIES | AUTM | 4th Quarter - Report | $9,000.00 | 2022 | 01/12/2023 @ 11:01 AM |
WARING FEDERAL STRATEGIES | AUTM | 3rd Quarter - Report | $20,000.00 | 2024 | 10/07/2024 @ 12:37 PM |
W STRATEGIES, LLC | CALIFORNIA LIFE SCIENCES | 2nd Quarter - Report | $30,000.00 | 2016 | 07/19/2016 @ 05:04 PM |
W STRATEGIES, LLC | CALIFORNIA LIFE SCIENCES | 1st Quarter - Report | $30,000.00 | 2016 | 04/20/2016 @ 06:36 PM |
YALE UNIVERSITY | YALE UNIVERSITY | 1st Quarter - Report | $150,000.00 | 2010 | 04/21/2010 @ 11:01 AM |